Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. a critical analysis
Ernst, E.
Münchener Medizinische Wochenschrift 125(37): 796-798
1983
ISSN/ISBN: 0341-3098 PMID: 6415441 Document Number: 203824
Document emailed within 1 workday
Related Documents
Alexander, K. 1993: Conservative therapy of peripheral arterial occlusive diseases Zeitschrift für Kardiologie 82(Suppl): 89-98Spittell, J.A. 1992: Conservative management of occlusive peripheral arterial disease Cardiovascular Clinics 22(3): 209-215
Rieger, H. 1989: Conservative therapy of arterial occlusive disease Herz 14(1): 1-11
Périard, D.; Hayoz, D.; Mazzolai, L. 2009: Medical therapy in peripheral arterial occlusive disease Revue Medicale Suisse 5(189): 312-315
Kiesewetter, H.; Jung, F. 1984: Hemorheologic therapy in peripheral arterial occlusive disease Fortschritte der Medizin 102(37): 921-924
Sailer, S.; Pilger, E. 1985: Fibrinolytic therapy of peripheral arterial occlusive disease Wiener Medizinische Wochenschrift 135(15-16): 393-399
Altmann, E.; Stelzner, C.; Graf, A. 1999: Fibrinolytic, revascularizing therapy of peripheral arterial occlusive disease Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 93(9): 651-658
Creutzig, A. 1991: Therapy of peripheral arterial occlusive disease with special reference to prostaglandins Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 46(3): 59-67
Marshall, M. 1982: Thrombocyte function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 1. Pathogenesis, prevention, therapy Fortschritte der Medizin 100(14): 650-655
Lebrun, T.; Selke, B.; Sailly, J.C.; Boissier, C.; Mosnier, M. 1994: The introduction of economic criteria into the management of arterial disease: an illustration with regard to the socioeconomic consequences of peripheral occlusive arterial disease of the lower limbs Journal of Cardiovascular Pharmacology 23(Suppl 3): S17-S21
Kiesewetter, H.; Jung, F.; Erdlenbruch, W.; Wenzel, E. 1992: Haemodilution in patients with peripheral arterial occlusive disease International Angiology: a Journal of the International Union of Angiology 11(3): 169-175
Kröger, K. 2005: Peripheral arterial occlusive disease--the forgotten arteriosclerosis MMW Fortschritte der Medizin 147(18): 21
Spittell, J.A. 1982: Diagnosis and treatment of occlusive peripheral arterial disease Geriatrics 37(1): 57-67
Ratnatunga, C. 1998: Chronic peripheral occlusive arterial disease in Sri Lanka Ceylon Medical Journal 43(4): 182-184
Cole, C.W.; Hill, G.B.; Farzad, E.; Bouchard, A.; Moher, D.; Rody, K.; Shea, B. 1993: Cigarette smoking and peripheral arterial occlusive disease Surgery 114(4): 753
Stalnikowicz-Darvasi, R. 1995: Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis Journal of Clinical Gastroenterology 21(1): 13-16
Ahmadi, R.A.; Minar, E.; Marosi, L.; Kretschmer, G.; Ehringer, H. 1988: Percutaneous transluminal angioplasty in peripheral arterial occlusive disease Acta Medica Austriaca 15(2): 45-50
Dormandy, J.A. 1992: Natural history of patients with peripheral occlusive arterial disease Annales Chirurgiae et Gynaecologiae 81(2): 86-88
Ucchino, S.; Nardi, M.; Santarelli, M.; Legnini, M.; Costantini, A.; Ucchino, G.; Napolitano, A.M. 1992: The treadmill test in the assessment of peripheral arterial occlusive disease Panminerva Medica 34(3): 120-123
Johnston, K.W.; Colapinto, R.F.; Harries-Jones, E.P.; DeMorais, D.; Kalman, P.G.; Baird, R.J.; Goldman, B.S.; Key, J.A.; Weisel, R.D. 1980: Transluminal dilatation in the treatment of peripheral arterial occlusive disease Canadian Journal of Surgery. Journal Canadien de Chirurgie 23(6): 547-548